However, we found a strong negative correlation between the tumour levels of total/PD-1+ CD8+ T cells and tumour size specifically in the ATO/PD-L1-treated group, which reflects the activation of a CD8+ T cell-mediated response in those tumours with delayed growth (Fig. 2H, I). The gene discussed is PDCD1; the disease is neoplasm.